Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,269 | 41,625 | 31,062 | 51,536 | 40,435 |
| Marketable Securities | 244,693 | 165,135 | 57,682 | N/A | N/A |
| Receivables | 19,928 | 17,588 | 28,196 | 9,860 | 6,221 |
| Inventories | 5,424 | 4,732 | 4,576 | 2,329 | 1,682 |
| TOTAL | $307,358 | $236,820 | $124,185 | $65,689 | $48,980 |
| Non-Current Assets | |||||
| PPE Net | 1,050 | 655 | 518 | 205 | 98 |
| Investments And Advances | 39,352 | 0 | 15,281 | 0 | 0 |
| Other Non-Current Assets | 64,552 | 74,219 | 80,553 | 2,859 | 2,824 |
| TOTAL | $104,954 | $74,874 | $96,352 | $3,064 | $2,922 |
| Total Assets | $412,312 | $311,694 | $220,537 | $68,753 | $51,902 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 14,664 | N/A |
| Accounts payable and accrued liabilities | 7,537 | 8,266 | 8,579 | 2,290 | 1,325 |
| Accrued Expenses | 6,477 | 3,521 | 2,247 | 1,467 | 1,171 |
| TOTAL | $38,841 | $35,573 | $29,569 | $27,374 | $20,876 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 158 |
| Other Non-Current Liabilities | 1,903 | 0 | 0 | 0 | 0 |
| TOTAL | $2,289 | $239 | $N/A | $N/A | $12,528 |
| Total Liabilities | $41,130 | $35,812 | $29,569 | $27,374 | $33,404 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,595 | 114,723 | 114,830 | 112,942 | 109,661 |
| Common Shares | 120 | 117 | 115 | 113 | 110 |
| Retained earnings | -23,555 | -117,736 | -193,146 | -322,268 | -330,408 |
| Other shareholders' equity | 557 | 273 | -75 | 0 | 0 |
| TOTAL | $371,182 | $275,882 | $190,968 | $41,379 | $18,498 |
| Total Liabilities And Equity | $412,312 | $311,694 | $220,537 | $68,753 | $51,902 |